Wonderful to see so many people attend the Annual @SAiGENCI Public Lecture last night to hear our research on the innate immune system, inflammation and immunotherapy in cancer. Fantastic talk also from my co-speaker @marazeissig. Thank you to everyone.
https://t.co/AUjKATY6Jm
Very pleased to share our latest published work on the role of the innate immune inflammasome adaptor ASC in promoting pancreatic cancer. Thanks to all in our multinational team!
@SAiGENCI@NatureComms
https://t.co/9OjWnIcR3C
Great to see so many excellent presentations by national experts in inflammation, innate immunity and cell death at the 5th Annual Australian Inflammation Centres Symposium hosted by @SAiGENCI in Adelaide. Thanks to ASI Innate Immunity SIG, and @AusCellDeathSoc.
Very honoured to be the first Australian recipient of the prestigious Japanese Cancer Association (JCA) International Award, presented at the annual JCA2025 conference in Kanazawa. Special thanks to my JCA colleagues, especially JCA President, Prof Masanobu Oshima
@SAiGENCI
Very honoured to be the first Australian recipient of the prestigious Japanese Cancer Association (JCA) International Award, presented at the annual JCA2025 conference in Kanazawa. Special thanks to my JCA colleagues, especially JCA President, Prof Masanobu Oshima
@SAiGENCI
We're hiring! Looking for highly talented Post-doctoral researchers to join our program at SAiGENCI (Adelaide University) to study the role of the immune system in cancer. See below for details.....
https://t.co/LqmFTsVbzW
@SAiGENCI
We're hiring! Looking for highly talented Post-doctoral researchers to join our program at SAiGENCI (Adelaide University) to study the role of the immune system in cancer. See below for details.....
https://t.co/LqmFTsVbzW
@SAiGENCI
Very grateful to the Ainsworth Foundation for their generous investment in our Tumour Inflammation and Immunotherapy Program.
@SAiGENCI@UniofAdelaide
https://t.co/jwBXpOWEjp
Very grateful to the Ainsworth Foundation for their generous investment in our Tumour Inflammation and Immunotherapy Program.
@SAiGENCI@UniofAdelaide
https://t.co/jwBXpOWEjp
Great to see a full-house for @SAiGENCI's third Annual Public Lecture on Tuesday night featuring @Lab_Jenkins and @marazeissig speaking on the topic of "Fighting cancer from within: your immune system may hold the key" https://t.co/cyM2wx9iOT @UniofAdelaide
Wonderful to see so many people attend the Annual @SAiGENCI Public Lecture last night to hear our research on the innate immune system, inflammation and immunotherapy in cancer. Fantastic talk also from my co-speaker @marazeissig. Thank you to everyone.
https://t.co/AUjKATY6Jm
"Bluesky is much better for science. There is much less toxicity, misinformation, and distractions." https://t.co/EZlY9KLXG7… please come join https://t.co/nRiD4zr3Gx on Bluesky!!!
Excited to have been awarded a Tour de Cure grant to work on KRAS inhibitors in pancreatic cancers. Marks the first grant (of hopefully many!) for my new lab at SAiGENCI 🎉